315
Participants
Start Date
December 14, 2020
Primary Completion Date
January 25, 2022
Study Completion Date
February 9, 2022
Norketotifen
Oral capsule
Placebo
Oral capsule
Frontier Clinical Research, Smithfield
Frontier Clinical Research, Scottdale
Continental Clinical Solutions, Towson
Frontier Clinical Research, Morgantown
Relief Integrated Health Care, Louisburg
Clinovacare Medical Research Center, West Columbia
Omega Research Debary, DeBary
South Florida Research Center, Miami
Premier Research Associate, Miami
Research Institute of South Florida, Miami
The Chappel Group Research, Kissimmee
Clinical Research Solutions, Jackson
Clinical Research Solutions, Middleburg Heights
Health Concepts, Rapid City
Horizon Research Group of Opelousas, Eunice
Cedar Health Research, Dallas
Advanced Medical Group, Houston
Precision Trials AZ, Phoenix
Clinical Research of South Nevada, Las Vegas
Downtown LA Research Center, Los Angeles
Lead Sponsor
Emergo Therapeutics, Inc.
INDUSTRY